The U.S. Securities and Exchange Commission filed a lawsuit Monday against an Amazon finance manager accused of leaking confidential company information to family members, allowing them to make nearly $1.4 million by trading based on insider tips. The stock market is on a downward trajectory right now, and ETFs could keep your money safer than stocks. Atrial Fibrillation Surgery Market by Surgical Procedure (Catheter Ablation Procedure, Surgical Ablation, Maze Procedure), Product (Catheter Ablation, Surgical Ablation), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027
SEATTLE (AP) – The U.S. Securities and Exchange Commission filed a lawsuit Monday against an Amazon finance manager accused of leaking confidential company information to family members, allowing them to make nearly $1.4 million by trading based on insider tips.
Laksha Bohra, a former manager in Amazon’s tax division who lives in Bothell, Washington; her husband, Viky Bohra; and father-in-law Gotham Bohra have agreed to pay back the stock gains, as well as another $1.2 million in penalties and interest, The Seattle Times reported.
The U.S. attorney also filed criminal charges against Viky Bohra. A spokesperson for the U.S. attorney’s office declined to comment to the newspaper about the fact that no other family members were criminally charged.
“Vik Bohra deeply regrets this conduct, accepts full responsibility, and intends to promptly repay the funds,” lawyer Peter Offenbecher said in a statement. An attorney for Laksha Bohra declined to comment. Gotham Bohra could not be reached.
Laksha Bohra, the SEC’s civil complaint alleged, ignored reminders from Amazon not to divulge confidential financial information or to illegally trade in the company’s securities based on her knowledge about the company’s financial position.
Between 2016 and 2018, Viky and Gotham Bohra “regularly” traded in Amazon securities based on confidential insider information from Laksha Bohra, the complaint said.
While vacationing in Europe in 2018, for example, Laksha Bohra logged into Amazon’s network to view the company’s preliminary first-quarter earnings statements. The same day, Viky and Gotham Bohra purchased options to buy Amazon shares at a specified price, the complaint alleged. The shares rose after the earnings report – by 3.6% in one day, netting the Bohras nearly $600,000 in profit on the stock trades.
Amazon declined to respond to questions about how it prevents insider trading, or whether officials were aware of the alleged acts by Laksha Bohra when the company suspended her employment in October 2018.
Copyright © 2020 The Washington Times, LLC.
Author: The Washington Times http://www.washingtontimes.com
3 Reasons ETFs Are Safer Than Single Stocks If the Market Keeps Falling
After months of remarkable growth, the stock market took a turn for the worse in early September and is now veering into correction territory, meaning it’s fallen by at least 10% from its most recent peak. And as the COVID-19 pandemic rages on and Americans face an uncertain upcoming election, there’s a chance the market could become even more volatile in the coming months.
While it’s uncertain whether a full-fledged market crash is on the horizon, it’s a good idea to prepare your investments for the worst just in case. And if you’re concerned about losing money, there are three reasons why you might want to invest in ETFs rather than individual stocks.
Image source: Getty Images.
Exchange-traded funds (ETFs) are essentially large groupings of stocks, bonds, or other securities all lumped together into a single investment. Some ETFs contain hundreds or even thousands of stocks, and that instant diversification can lower your risk substantially.
When you’re investing, you don’t want to put all your eggs in one basket. If you’re investing in individual stocks, it’s wise to invest in at least 10 to 15 different companies to limit your risk. That can get expensive, though, and your portfolio could still take a tumble if even one or two of those stocks don’t perform well.
With an ETF, however, you can invest in hundreds of different stocks without breaking the bank. Even if several of those stocks nosedive, it likely won’t make a significant dent in your portfolio.
There are different types of ETFs out there, and one of the most popular options is the index ETF. Index ETFs track stock market indexes, such as the S&P 500 or the Dow Jones Industrial Average, meaning the ETF contains all the stocks within the particular index it tracks. Index ETFs are among the safest investments out there, because the indexes themselves have always managed to recover from past market crashes.
^SPX data by YCharts
In the short-term, the stock market may face extreme volatility. But over the long run, these indexes experience positive returns. And because index ETFs simply follow the market, they’re very likely to recover from even the worst market crashes.
The downside to index ETFs is that you have no say in the companies that are included in the index. But even if you’re more of a hands-on investor who wants greater control of the companies you invest in, there’s likely still an ETF out there that will fit your needs.
There are seemingly unlimited ETF options out there, from broad funds that track the entire stock market to narrow investments that focus on a certain industry or sector. Some ETFs only include tech stocks. Others may be limited to real estate companies, healthcare organizations, or even pet care brands.
If you want to take a more personalized approach to investing, you may opt to invest in industry-specific ETFs. The advantage here over individual stocks is that each ETF contains multiple stocks — so you’re still diversifying and limiting your risk.
The future of the stock market may be uncertain, but that doesn’t mean it’s a bad time to invest. As long as you’re investing in the right places and doing your best to limit your risk, you can set your investments up for long-term success.
Author: Katie Brockman
Global Atrial Fibrillation Surgery Market Is Expected to Reach USD 5.20 billion by 2027 : Fior Markets
Newark, NJ, Sept. 28, 2020 (GLOBE NEWSWIRE) — As per the report published by Fior Markets, the global atrial fibrillation surgery market is expected to grow from USD 1.7 billion in 2019 and to reach USD 5.20 billion by 2027, growing at a CAGR of 15% during the forecast period 2020-2027.
The global atrial fibrillation surgery market is witnessing significant growth from recent years. This growth is attributed to increasing healthcare expenditure, an increasing number of people suffering from atrial fibrillation, and a larger prevalence of catheter and surgical ablation treatments. Ambulatory surgical center, due to the availability of skilled labor, healthcare infrastructure, and availability will influence the market. Growing cases of heart patients and a rise in the number of cases of atrial fibrillation will propel the market growth.
Atrial fibrillation surgery is a surgical procedure used for the treatment of irregular rhythm, which starts in the uppermost chamber of the heart (atria). It is also called as AFib or AF. Atrial fibrillation escalates the risk of stroke five to seven times. The different types of surgery used to treat atrial fibrillation are ablation surgeries, atrioventricular node ablation, and maze procedure. Atrial fibrillation is a type of cardiac ablation that works by destroying or scarring tissues in the heart to disrupt faulty electric signals that give rise to arrhythmia. In atrial fibrillation, an electrical signal which coordinates with the two chambers of the heart does not work together, which in turn causes the heart to contract erratically. This results in the heart to beat too fast or too slow, or even irregularly.
The global atrial fibrillation surgery market is expected to witness significant growth, owing to the increasing heart problems among the aging population, expanding pharmacies and drug stores, increasing awareness about different treatments, and positive outcomes of atrial fibrillation devices. However, stringent product approval regulations and high cost of the treatment will hamper the market growth. The factor providing market growth opportunity is the increased prevalence of obesity.
DOWNLOAD FREE SAMPLE REPORT AT https://www.fiormarkets.com/report-detail/418888/request-sample
Some of the key players operating in global atrial fibrillation surgery market are AtriCure Inc., Sanofi-Aventis, Johnson & Johnson Ltd., Boston Scientific Corporation, CardioFocus Inc., Boehringer Ingelheim GmbH., Biosense Webster Inc., Endoscopic Technologies Inc., Bristol-Myers Squibb Corporation, and St. Jude Medical Inc. To gain a significant market share in the global atrial fibrillation surgery market, the key players are now focusing on adopting strategies such as product innovations, mergers & acquisitions, recent developments, joint venture, collaborations, and partnership. Johnson & Johnson and CardioFocus Inc. are the key players operating in atrial fibrillation surgery.
- For instance, In May 2020, CardioFocus Inc. HeartLight X3 Endoscopic ablation system was approved by US FDA for the treatment of drug-refractory recurrent symptomatic paroxysmal atrial fibrillation.
Catheter Ablation Procedure segment dominated the market and held the largest share of 41.7% in the year 2019
On the basis of surgical procedure, the global atrial fibrillation surgery market is segmented into catheter ablation procedure, surgical ablation, and maze procedure. Catheter ablation procedure segment dominated the market and held the largest share of 41.7% in the year 2019. This growth is attributed to growing patient awareness, increasing demand for non-pharmaceutical treatments, and improved healthcare groundwork.
Catheter Ablation product segment dominated the market and held the largest share of 54.9% in the year 2019
On the basis of product, the global atrial fibrillation surgery market is segmented into catheter ablation and surgical ablation. Catheter ablation product segment dominated the market and held the largest share of 54.9% in the year 2019. This growth is attributed to the high acceptance of the product in surgical procedures.
Browse full report with TOC at https://www.fiormarkets.com/report/atrial-fibrillation-surgery-market-by-surgical-procedure-catheter-418888.html
Regional Segment of Atrial Fibrillation Surgery Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and Rest of South America)
- Middle East and Africa (UAE, South Africa, Rest of MEA)
On the basis of geography, the global atrial fibrillation surgery market is classified into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America held the major share of 34.2% in the year 2019. This growth was attributed to the presence of high procedure volumes supported by the presence of sophisticated healthcare infrastructure, healthcare expenditure levels, and high awareness among patients. In the region, the U.S. holds the largest share, owing to the large number of people suffering from the country’s disease and the rising number of geriatric population. The European market holds the second-largest share, owing to the growing elder population and high prevalence of atrial fibrillation. In the European region, the U.K. holds the largest share, owing to the rising healthcare awareness and rising incidences of atrial fibrillation. Germany is anticipated to witness significant growth, owing to the adoption of the latest technologies. The Asia-Pacific region market is projected to witness significant growth, owing to the large number of geriatric population who has a high risk of heart diseases. Due to the presence of a huge patient pool and rising healthcare expenditure, China holds the largest share in the Asia-Pacific region. Brazil is the leading nation in the Latin America region due to the development of the healthcare sector.
Request for Customization: https://www.fiormarkets.com/enquiry/request-customization/418888
About the report:
The global atrial fibrillation surgery market is analysed on the basis of value (USD billion). All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insights of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitors’ position grid analysis.
For Instant Purchase: https://www.fiormarkets.com/checkout.html?reportid=418888&type=single
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on [email protected] or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
About Fior Markets
Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients’ objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.
Head of Business Development
Email: [email protected]
To Know More Market Research Reports and Industry Analysis, Visit our Associate Website: https://marketandresearch.biz
Healthcare Supply Chain BPO Market – https://www.fiormarkets.com/report/healthcare-supply-chain-bpo-market-by-payer-service-418827.html
Lentiviral Vectors Market – https://www.fiormarkets.com/report/lentiviral-vectors-market-by-disease-infectious-diseases-genetic-418828.html
Blood Glucose Monitoring Systems Market – https://www.fiormarkets.com/report/blood-glucose-monitoring-systems-market-by-product-continuous-418818.html
Capillary and Venous Blood Sampling Devices Market – https://www.fiormarkets.com/report/capillary-and-venous-blood-sampling-devices-market-by-418819.html
Author: Fior Market Research LLP